InsidersTradesSigma
Follow the 바이오텐 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오텐 has recorded 9 insider filings. The latest transaction was reported on 6 November 2025 (Sale). Among the most active insiders: 파인밸류자산운용. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
9 of 9 declarations
Bio10是一家在XKRX市场上市的医疗保健和制药公司。它专注于开发医疗保健领域的创新解决方案。